| Title | Author(s) | Issue date | ???itemlist.??? |
| Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study | Katsanos, K. H.; Tatsioni, A.; Pedersen, N.; Shuhaibar, M.; Ramirez, V. H.; Politi, P.; Rombrechts, E.; Pierik, M.; Clofent, J.; Beltrami, M.; Bodini, P.; Freitas, J.; Mouzas, I.; Fornaciari, G.; Moum, B.; Lakatos, P. L.; Vermeire, S.; Langholz, E.; Odes, S.; Morain, C. O.; Stockbrugger, R.; Munkholm, P.; Tsianos, E. V. | 24-Nov-2015 | - |
| Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study | Katsanos, K. H.; Vermeire, S.; Christodoulou, D. K.; Riis, L.; Wolters, F.; Odes, S.; Freitas, J.; Hoie, O.; Beltrami, M.; Fornaciari, G.; Clofent, J.; Bodini, P.; Vatn, M.; Nunes, P. B.; Moum, B.; Munkholm, P.; Limonard, C.; Stockbrugger, R.; Rutgeerts, P.; Tsianos, E. V. | 24-Nov-2015 | - |
| Intravenous iron therapy restores functional iron deficiency induced by infliximab | Katsanos, K.; Cavalier, E.; Ferrante, M.; Van Hauwaert, V.; Henckaerts, L.; Schnitzler, F.; Katsaraki, A.; Noman, M.; Vermeire, S.; Tsianos, E. V.; Rutgeerts, P.; Chapelle, J. P.; Van Assche, G. | 24-Nov-2015 | - |
| Predictors of early response to infliximab in patients with ulcerative colitis | Ferrante, M.; Vermeire, S.; Katsanos, K. H.; Noman, M.; Van Assche, G.; Schnitzler, F.; Arijs, I.; De Hertogh, G.; Hoffman, I.; Geboes, J. K.; Rutgeerts, P. | 24-Nov-2015 | - |
| Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years | Hoie, O.; Aamodt, G.; Vermeire, S.; Bernklev, T.; Odes, S.; Wolters, F. L.; Riis, L.; Politi, P.; Tsianos, E. V.; Butron, M.; Stockbrugger, R. W.; Munkholm, P.; Vatn, M.; Moum, B. | 24-Nov-2015 | - |
